Last Posted: Mar 24, 2019
- The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Oh Mok et al. The Prostate 2019 Mar - A Randomized Controlled Intervention to Promote Readiness to Genetic Counseling for Breast Cancer Survivors.
Kasting Monica L et al. Psycho-oncology 2019 Mar - Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini Gianluca et al. Annali italiani di chirurgia 2019 901-2 - BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer.
Kwiatkowski Fabrice et al. Hereditary cancer in clinical practice 2019 177 - BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Kwon Janice S et al. Gynecologic oncology 2019 Mar 152(3) 459-464 - Quick Uptakes-Taking the Uncertainty Out of Interpreting BRCA Variants
R Voeller, JAMA, March 20, 2019 - Referral patterns for genetic counselling of women diagnosed with tubo-ovarian or peritoneal high-grade serous carcinoma (HGSC) within the Auckland Gynaecological Oncology Centre.
Burling Michael J et al. The Australian & New Zealand journal of obstetrics & gynaecology 2019 Mar - Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Clifton Katherine et al. Breast cancer research and treatment 2018 Jul 170(1) 101-109 - BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Wunderle Marius et al. Breast cancer research and treatment 2018 Aug 171(1) 85-94 - Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM).
Heinlen Christopher et al. Journal of genetic counseling 2019 Mar
.png)
No hay comentarios:
Publicar un comentario